Former UFC heavyweight champion Brock Lesnar has been notified by USADA of a potential Anti-Doping violation due to an out-competition drug test he recently submitted.
The potential Anti-Doping violation was announced by the UFC in a statement today.
“The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Brock Lesnar of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collection on June 28, 2016,” the UFC statement said. “USADA received the testing results from the June 28, 2016 sample collection from the WADA-accredited UCLA Olympic Analytical Laboratory on the evening of July 14, 2016.”
“USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed. The Nevada State Athletic Commission also retains jurisdiction over this matter as the sample collection was performed in close proximity to Lesnar’s bout at UFC 200 in Las Vegas.”
“Consistent with all previous potential anti-doping violations, additional information will be provided at the appropriate time as the process moves forward.”
Lesnar (6-3) scored a decision victory over Mark Hunt at UFC 200 and it was his first fight since the end of 2011 and following the news of the potential anti-doping violation, Lesnar issued a short statement to the Associated Press.
“We will get to the bottom of this,” Lesnar stated.